Browse hierarchy: [Ophthalmic (OP)](/submissions/OP) → [Subpart B — Diagnostic Devices](/submissions/OP/subpart-b%E2%80%94diagnostic-devices) → [21 CFR 886.1780](/submissions/OP/subpart-b%E2%80%94diagnostic-devices/886.1780) → HKM — Retinoscope, Battery-Powered

# HKM · Retinoscope, Battery-Powered

_Ophthalmic · 21 CFR 886.1780 · Class 1_

**Canonical URL:** https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HKM

## Overview

- **Product Code:** HKM
- **Device Name:** Retinoscope, Battery-Powered
- **Regulation:** [21 CFR 886.1780](/submissions/OP/subpart-b%E2%80%94diagnostic-devices/886.1780)
- **Device Class:** 1
- **Review Panel:** [Ophthalmic](/submissions/OP)
- **GMP exempt:** yes

## Identification

A retinoscope is an AC-powered or battery-powered device intended to measure the refraction of the eye by illuminating the retina and noting the direction of movement of the light on the retinal surface and of the refraction by the eye of the emergent rays.

## Classification Rationale

(1) Class II (special controls) for the AC-powered device. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9.(2) Class I (general controls) for the battery-powered device. The class I battery-powered device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 886.9. The battery-powered device is exempt from the current good manufacturing practice requirements of the quality management system regulation in part 820 of this chapter, except for requirements concerning records and complaint files under § 820.35 of this chapter.

## Special Controls

*Classification.* (1) Class II (special controls) for the AC-powered device. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9.(2) Class I (general controls) for the battery-powered device. The class I battery-powered device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 886.9. The battery-powered device is exempt from the current good manufacturing practice requirements of the quality management system regulation in part 820 of this chapter, except for requirements concerning records and complaint files under § 820.35 of this chapter.

## Recent Cleared Devices (7 of 7)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K964338](https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HKM/K964338.md) | RI-TINISCOPE-SLIT/RI-TINISCOPE SPOT/RI-VISION-SLIT/RI-VISION-SPOT | Rudolf Riester GmbH & Co. KG | Jan 9, 1997 | SESE |
| [K950795](https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HKM/K950795.md) | STREAK RETINOSCOPE RX-RP | Neitz Instruments Company, Ltd. | Mar 28, 1995 | SESE |
| [K950794](https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HKM/K950794.md) | STREAK RETINOSCOPE RX-RC | Neitz Instruments Company, Ltd. | Mar 28, 1995 | SESE |
| [K950793](https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HKM/K950793.md) | SPOT RETINOSCOPE RX-3SP | Neitz Instruments Company, Ltd. | Mar 28, 1995 | SESE |
| [K950792](https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HKM/K950792.md) | STREAK RETINOSCOPE RX-3A | Neitz Instruments Company, Ltd. | Mar 28, 1995 | SESE |
| [K950791](https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HKM/K950791.md) | STREAK RETINOSCOPE RX-3 | Neitz Instruments Company, Ltd. | Mar 28, 1995 | SESE |
| [K840840](https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HKM/K840840.md) | GENERATED RETINAL REFLEX IMAGERY SYS | Electro Optical Instruments | Jul 12, 1984 | SESE |

## Top Applicants

- Neitz Instruments Company, Ltd. — 5 clearances
- Electro Optical Instruments — 1 clearance
- Rudolf Riester GmbH & Co. KG — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HKM](https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HKM)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com